0
Article Tier 2 Sign in to save

Microplastics and nanoplastics in neurodegenerative disease: A scoping review

AI summary Read the abstract

This review of animal and human studies finds that tiny plastic particles may build up in the brain and are linked, in lab animals, to damage resembling Alzheimer's and Parkinson's disease. However, most studies used one lab-made plastic type, not real-world mixtures, so scientists can't yet say microplastics actually cause these diseases in people.

Polymers
Body Systems
Models

ABSTRACT Plastic pollution has become a global environmental concern, with microplastics and nanoplastics (MNPs) increasingly detected in human tissues, including the brain. This scoping review conducted in accordance with the SYRCLE and ROBINS-I Risk of Bias tool methodology and reported following the PRISMA extension for Scoping Reviews (PRISMA-ScR), synthesized current evidence on the potential association between MNP exposure and neurodegenerative diseases, particularly Alzheimer’s disease (AD) and Parkinson’s disease (PD). Following PRISMA guidelines, systematic searches identified 93 records and 13 eligible studies with two involving human subjects and eleven preclinical. Human data provide preliminary evidence that MNPs may be present in brain tissue, although recent methodological critiques have questioned the reliability of current detection methods in lipid-rich tissues. Preclinical studies provide more consistent mechanistic evidence. MNP exposure, predominantly polystyrene, was associated with oxidative stress, neuroinflammation, mitochondrial dysfunction, impaired autophagy, and neuronal apoptosis. In AD models, MNP exposure exacerbated tau phosphorylation, amyloid-β aggregation, and cognitive decline. In PD models, MNPs accelerated α-synuclein aggregation and dopaminergic neuron loss, and motor impairment through mechanisms including excessive mitophagy autophagosomelysosome disruption, and mitochondrial calcium dysregulation. Biodegradable polymers such as polylactic acid also demonstrated neurotoxic potential. The overwhelming reliance on polystyrene in experimental studies does not reflect actual environmental polymer distributions. Formal quality assessment revealed unclear risk of bias in several domains across preclinical studies. Accordingly, a causal relationship between MNP exposure and neurodegenerative disease has not yet been established. Further longitudinal studies using environmentally relevant exposures and validated analytical methods are needed to determine whether MNPs pose a genuine risk to neurological health.

More Papers Like This

Meta Analysis Tier 1

Nanoplastic exposure and protein aggregation in neurodegenerative and neurodevelopmental disease: a systematic review

AI summary Read the abstract

This review pulls together existing lab studies suggesting that tiny plastic particles may encourage brain proteins to clump together in ways linked to diseases like Alzheimer's and Parkinson's. However, the authors caution that many of these studies used unrealistic doses and poorly characterized plastic particles, so we can't yet say microplastics definitely cause these diseases in humans. More rigorous research is needed before drawing firm conclusions.

Article Tier 2

Plastics in the Brain: A Narrative Review of Central Nervous System Micro- and Nanoplastic Accumulation, Exposure Pathways, and the Underinvestigated Link to Neurodegenerative Disease

AI summary Read the abstract

Scientists have found tiny plastic particles in human brain tissue, and this review pulls together what we know about how they get there and what they might do once inside. Lab studies suggest these particles may trigger inflammation and stress in brain cells, processes linked to diseases like Alzheimer's and Parkinson's, but scientists haven't yet proven plastics actually cause these diseases in people. More research is needed to know how worried we should be.

Article Tier 2

Microplastics as Emerging Neurotoxins: Brain Accumulation, Neuroinflammation, and Neurodegeneration Risk

AI summary Read the abstract

This review pulls together recent studies showing that tiny plastic particles can build up in the human brain, with even higher levels found in people with dementia. Scientists think these particles may damage the brain's protective barrier and trigger inflammation and processes linked to Alzheimer's and Parkinson's disease. More research is needed, but this raises real concerns about plastic exposure and long term brain health.

Article Tier 2

Microplastics and Nanoplastics as Potential Contributors to Neurodegenerative Disease: Mechanistic Links to Dementia, Parkinson's Disease, Epilepsy, and Emerging Therapeutic Opportunities

AI summary Read the abstract

Researchers review how microplastics and nanoplastics may reach the brain via inhalation and systemic routes, proposing that chronic neuroinflammation, oxidative stress, and direct interactions with proteins like amyloid-β and α-synuclein could link particle exposure to Alzheimer's, Parkinson's, and other neurodegenerative conditions.

Article Tier 2

Nano- and Microplastics in the Brain: An Emerging Threat to Neural Health

AI summary Read the abstract

This review summarizes evidence that nano- and microplastics can cross the blood-brain barrier and accumulate in brain tissue, where they trigger oxidative stress, inflammation, and protein clumping linked to diseases like Alzheimer's and Parkinson's. The findings suggest that plastic particles may also interfere with the brain's ability to heal from injury, though long-term human studies are still lacking.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper